0000899243-20-013004.txt : 20200513
0000899243-20-013004.hdr.sgml : 20200513
20200513171531
ACCESSION NUMBER: 0000899243-20-013004
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200511
FILED AS OF DATE: 20200513
DATE AS OF CHANGE: 20200513
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GIANAKAKOS ANASTASIOS
CENTRAL INDEX KEY: 0001413822
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37609
FILM NUMBER: 20874193
MAIL ADDRESS:
STREET 1: 333 ALLERTON AVE.
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MyoKardia, Inc.
CENTRAL INDEX KEY: 0001552451
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 455500552
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1000 SIERRA POINT PARKWAY
CITY: BRISBANE
STATE: CA
ZIP: 94005
BUSINESS PHONE: 650-741-0900
MAIL ADDRESS:
STREET 1: 1000 SIERRA POINT PARKWAY
CITY: BRISBANE
STATE: CA
ZIP: 94005
FORMER COMPANY:
FORMER CONFORMED NAME: MyoKardia Inc
DATE OF NAME CHANGE: 20120618
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-05-11
0
0001552451
MyoKardia, Inc.
MYOK
0001413822
GIANAKAKOS ANASTASIOS
C/O MYOKARDIA, INC.
1000 SIERRA POINT PARKWAY
BRISBANE
CA
94005
1
1
0
0
President and CEO
Common Stock
2020-05-11
4
S
0
600
98.6883
D
63522
D
Common Stock
2020-05-11
4
S
0
1700
100.5056
D
61822
D
Common Stock
2020-05-11
4
S
0
18581
101.9044
D
43241
D
Common Stock
2020-05-11
4
S
0
3519
102.5635
D
39722
D
Common Stock
2020-05-11
4
S
0
600
103.33
D
39122
D
Common Stock
129407
I
By Reporting Person's Trust 2
Common Stock
300000
I
By Reporting Person's Trust 4
Common Stock
7000
I
By Reporting Person's Trust 5
Common Stock
10000
I
By Reporting Person's Trust 6
Common Stock
53087
I
By Trust 1
Common Stock
53087
I
By Trust 2
Common Stock
53087
I
By Trust 3
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
Represents the weighted average sale price of the shares sold ranging from $98.50 to $99.46 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the ranges reported in this footnote and footnotes 4 through 7.
Excludes 10,000 shares previously owned directly which were contributed on May 6, 2020 to the MJA Legacy Trust, of which the Reporting Person's children are beneficiaries.
Represents the weighted average price of the shares sold ranging from $100.01 to $100.94 per share.
Represents the weighted average price of the shares sold ranging from $101.07 to $102.05 per share.
Represents the weighted average price of the shares sold ranging from $102.11 to $103.09 per share.
Represents the weighted average price of the shares sold ranging from $103.19 to $103.54 per share.
Excludes 1,000 shares previously held by The TKG Trust dated November 2, 2006 which were redistributed back to the Reporting Person directly and immediately transferred to The TKG 2020 Irrevocable Trust on May 5, 2020.
Includes 1,000 shares previously held by The TKG Trust dated November 2, 2006 which were redistributed back to the Reporting Person directly and immediately transferred to The TKG 2020 Irrevocable Trust on May 5, 2020.
Includes 10,000 shares previously owned directly which were contributed on May 6, 2020 to the MJA Legacy Trust, of which the Reporting Person's children are beneficiaries.
/s/ Cynthia Ladd, as Attorney-in-Fact
2020-05-13